Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$10.52 - $20.68 $67,328 - $132,352
6,400 Added 6.64%
102,800 $1.12 Million
Q2 2023

Aug 09, 2023

BUY
$17.18 - $23.76 $134,004 - $185,328
7,800 Added 8.8%
96,400 $2.11 Million
Q1 2023

May 10, 2023

SELL
$18.25 - $30.26 $180,675 - $299,574
-9,900 Reduced 10.05%
88,600 $1.63 Million
Q4 2022

Feb 08, 2023

BUY
$12.36 - $26.41 $27,192 - $58,102
2,200 Added 2.28%
98,500 $2.54 Million
Q3 2022

Nov 09, 2022

BUY
$14.67 - $21.7 $24,939 - $36,890
1,700 Added 1.8%
96,300 $1.53 Million
Q1 2022

May 09, 2022

BUY
$34.22 - $47.24 $280,604 - $387,368
8,200 Added 9.49%
94,600 $4.3 Million
Q3 2021

Nov 08, 2021

BUY
$36.86 - $54.98 $25,802 - $38,486
700 Added 0.82%
86,400 $4.27 Million
Q2 2021

Aug 06, 2021

BUY
$41.49 - $59.92 $3.56 Million - $5.14 Million
85,700 New
85,700 $4.28 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.